Cervical Cancer in Ethiopia: The Effect of Adherence to Radiotherapy on Survival

被引:25
|
作者
Moelle, Ulrike [1 ]
Mathewos, Assefa [2 ]
Aynalem, Abreha [2 ]
Wondemagegnehu, Tigeneh [2 ]
Yonas, Bekuretsion [2 ]
Begoihn, Matthias [1 ]
Addissie, Adamu [2 ]
Unverzagt, Susanne [1 ]
Jemal, Ahmedin [3 ]
Thomssen, Christoph [1 ]
Vordermark, Dirk [1 ]
Kantelhardt, Eva J. [1 ]
机构
[1] Martin Luther Univ Halle Wittenberg, Halle, Saale, Germany
[2] Addis Ababa Univ, Addis Ababa, Ethiopia
[3] Amer Canc Soc, Atlanta, GA 30329 USA
来源
ONCOLOGIST | 2018年 / 23卷 / 09期
关键词
Cervical cancer; Radiotherapy; Sub-Saharan Africa; Survival; Adherence; SQUAMOUS-CELL CARCINOMA; DOSE-RATE BRACHYTHERAPY; RADIATION-THERAPY; UTERINE CERVIX; WORLDWIDE BURDEN; EXTERNAL-BEAM; AFRICA; IRRADIATION; GUIDELINES; EXPERIENCE;
D O I
10.1634/theoncologist.2017-0271
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Discontinuation of radiotherapy (RT) for cervical cancer (CC) in sub-Saharan Africa is common because of patient-and health service-related reasons. This analysis describes toxicities and the effect of adherence on survival. Materials and Methods. A total of 788 patients with CC (2008-2012) who received RT at Addis Ababa University Hospital were included. External beam RT without brachytherapy was performed according to local guidelines. We previously described survival and prognostic factors. Now we analyzed adherence and survival according to total doses received. Adjustment via multivariate cox regression analysis was done. Results. One-year overall survival (OS) after radical RT (n=180) for International Federation of Gynecology and Obstetrics (FIGO) stages IIA-IIIA was 89% for discontinuation (< 72 Gy) and 96% for adherence (>= 72 Gy; hazard ra tio [HR], 1.3; 95% confidence interval [CI], 0.5-3.3). One-year OS after nonradical RT (n=389) for FIGO stages IIIB-IVA was 71% for discontinuation (< 40 Gy) and 87% for adherence (44-50 Gy; HR, 3.1; 95% CI, 1.4-6.9). One-year OS for FIGO stages IIIB-IVB (n=219) after one compared with two or more palliative single fractions of 10 Gy were 14% and 73% respectively (HR, 7.3; 95% CI, 3.3-16). Reasons for discontinuation were toxicities, economic background, and RT machine breakdown. Grade 1-2 late toxicities were common (e.g., 30% proctitis, 22% incontinence). Grade 3 early and late toxicities were seen in 5% and 10% respectively; no grade 4 toxicities occurred. Conclusion. Patients who adhered to guideline-conforming RT had optimum survival. Better supportive care, brachytherapy to reduce toxicities, socioeconomic support, and additional radiation capacities could contribute to better adherence and survival.
引用
收藏
页码:1024 / 1032
页数:9
相关论文
共 50 条
  • [11] Malnutrition is associated with poor survival in women receiving radiotherapy for cervical cancer
    Laan, Janna
    van Lonkhuijzen, Luc
    Hinnen, Karel
    Pieters, Bradley
    Dekker, Inge
    Stalpers, Lukas
    Westerveld, Henrike
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (04) : 497 - 503
  • [12] Effect of radiotherapy on anorectal function in patients with cervical cancer
    Iwamoto, T
    Nakahara, S
    Mibu, R
    Hotokezaka, M
    Nakano, H
    Tanaka, M
    DISEASES OF THE COLON & RECTUM, 1997, 40 (06) : 693 - 697
  • [13] Radiotherapy of cervical cancer
    Chargari, C.
    Peignaux, K.
    Escande, A.
    Renard, S.
    Lafond, C.
    Petit, A.
    Kee, D. Lam Cham
    Durdux, C.
    Haie-Meder, C.
    CANCER RADIOTHERAPIE, 2022, 26 (1-2): : 298 - 308
  • [14] Radiotherapy of Cervical Cancer
    Vordermark, Dirk
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (09) : 516 - 520
  • [15] Effect of 2 Interventions on Cervical Cancer Screening Guideline Adherence
    Moscicki, Anna-Barbara
    Chang, Charlene
    Vangala, Sitaram
    Zhou, Xinkai
    Elashoff, David A.
    Dehlendorf, Christine
    Sawaya, George F.
    Kuppermann, Miriam
    Duron, Ysabel
    Wyand, Fred L.
    Navarro, Sandy K.
    de Bocanegra, Heike Thiel
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2021, 60 (05) : 666 - 673
  • [16] The addition of chemotherapy to adjuvant radiotherapy in patients with intermediate-risk stage IB cervical cancer and the effect on survival
    Pereira, E.
    Nair, N.
    Gorski, J.
    Schwartz, M. A.
    Zakashansky, K.
    Dottino, P.
    Kolev, V.
    Hayes, M. P.
    GYNECOLOGIC ONCOLOGY, 2017, 145 : 134 - 134
  • [17] THE EFFECT OF RADIOTHERAPY ON DYSPHAGIA AND SURVIVAL IN PATIENTS WITH ESOPHAGEAL CANCER
    CASPERS, RJL
    WELVAART, K
    VERKES, RJ
    HERMANS, J
    LEER, JWH
    RADIOTHERAPY AND ONCOLOGY, 1988, 12 (01) : 15 - 23
  • [18] The population benefit of radiotherapy for cervical cancer: Local control and survival estimates for optimally utilized radiotherapy and chemoradiation
    Hanna, T. P.
    Shafiq, J.
    Delaney, G. P.
    Barton, M. B.
    RADIOTHERAPY AND ONCOLOGY, 2015, 114 (03) : 389 - 394
  • [19] Prognostic Factors for Survival in Patients With Recurrent Cervical Cancer Previously Treated With Radiotherapy
    Mabuchi, Seiji
    Isohashi, Fumiaki
    Yoshioka, Yasuo
    Temma, Kumiko
    Takeda, Takashi
    Yamamoto, Toshiya
    Enomoto, Takayuki
    Morishige, Kenichirou
    Inoue, Takehiro
    Kimura, Tadashi
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2010, 20 (05) : 834 - 840
  • [20] Concurrent cisplatin-based radiotherapy and chemotherapy improves survival of cervical cancer
    Dunst, J
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 1999, 175 (06) : 257 - 258